Home > Journals > International Angiology > Past Issues > International Angiology 2018 February;37(1) > International Angiology 2018 February;37(1):12-8

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

INTERNATIONAL ANGIOLOGY

A Journal on Angiology


Official Journal of the International Union of Angiology, the International Union of Phlebology and the Central European Vascular Forum
Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,37


eTOC

 

ORIGINAL ARTICLE  


International Angiology 2018 February;37(1):12-8

DOI: 10.23736/S0392-9590.17.03825-1

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Comparison of clinical outcomes of pharmaco-mechanical thrombectomy in iliac vein thrombosis with and without May-Thurner syndrome

In-Sub KIM 1, Won-Min JO 1 , Hwan-Hoon CHUNG 2, Seung-Hwa LEE 2

1 Department of Thoracic and Cardiovascular Surgery, Ansan Hospital, Korea University Medical Center, Korea University College of Medicine, Ansan, South Korea; 2 Department of Radiology, Ansan Hospital, Korea University Medical Center, Korea University College of Medicine, Ansan, South Korea


PDF  


BACKGROUND: May-Thurner syndrome (MTS) has a different etiology from that of general deep vein thrombosis (DVT). However, few clinical comparisons of MTS-induced and non-MTS-induced DVT have been reported. The aim of this study was to analyze the clinical results of pharmaco-mechanical thrombectomy (PMT) in DVT with and without MTS.
METHODS: Forty-seven iliac vein thrombosis patients treated with PMT between January 2008 and December 2013 were enrolled. 25 patients had DVT with MTS and 22 patients had iliac vein DVT without MTS. We retrospectively reviewed medical records and analyzed mid-term patencies and post-thrombotic syndrome (PTS) occurrence by Villalta Score.
RESULTS: The median follow-up period was 48.4 (36~92) months. A venous stent was inserted in the iliac vein in all MTS patients. One-/two-/three-year primary patencies in the non-MTS group were 77.3% (N.=17) for all three years in the non-MTS group and were 96.0% (N.=24), 83.1% (N.=22), and 83.1% (N.=22) in the MTS group for years 1/2/3, respectively. One-/two-/three-year secondary patencies were 90.9% (N.=20) for all three years in the non-MTS group and were 96.0% (N.=24), 91.4% (N.=23), and 91.4% (N.=23) in the MTS group, respectively. One-, two-, and three-year Villalta Scores were 4.3, 3.9, and 3.4, respectively, in the non-MTS group, and 3.8, 3.7, and 4.0, respectively, in the MTS group. Primary and secondary patency and Villalta Score were not significantly different between the MTS and non-MTS groups.
CONCLUSIONS: Although MTS and DVT have different etiologies, clinical results for both diseases using PMT were not significantly different. Therefore, PMT can be offered as an acceptable initial therapy in DVT patients with and without MTS.


KEY WORDS: May-Thurner syndrome - Venous thrombosis - Thrombectomy - Post-thrombotic syndrome

top of page

Publication History

Issue published online: January 2, 2018
Article first published online: March 14, 2017
Manuscript accepted: March 9, 2017
Manuscript received: February 9, 2017

Cite this article as

Kim IS, Jo WM, Chung HH, Lee SH. Comparison of clinical outcomes of pharmaco-mechanical thrombectomy in iliac vein thrombosis with and without May-Thurner syndrome. Int Angiol 2018;37:12-8. DOI: 10.23736/S0392-9590.17.03825-1

Corresponding author e-mail

jowonmin@korea.ac.kr